The role of CREB and other transcription factors in the pharmacotherapy and etiology of depression
- 1 January 2002
- journal article
- research article
- Published by Taylor & Francis in Annals of Medicine
- Vol. 34 (5) , 348-356
Abstract
Psychiatric diseases are genetically complex and consequently, altered programs of gene expression have been hypothesized as the molecular basis of psychopathology. Since transcription factors represent the final communicative link between receptor activation and the orchestration of programs of gene expression, they are prime targets for studies on both the pharmacotherapy and the etiology of depression. The cyclic AMP response element binding protein (CREB) and the glucocorticoid receptor (GR) are altered by chronic treatment with antidepressants. Since it is phosphorylated CREB (pCREB) that determines its transcriptional activity, it is pertinent that some antidepressants have been shown to reduce pCREB in brain in vivo and in tissue culture in vitro. Moreover, pCREB is downregulated in human fibroblasts from patients with major depression and in postmortem brain of suicide victims with a history of depression. With regard to GR, its mRNA, immunoreactivity, density and cytoplasmic-nuclear translocation are increased by antidepressants. While transcription factor mediated programs of gene expression relevant to either the pharmacotherapy or the etiology of depression are still largely elusive, studies utilizing modern technologies such as differential display and cDNA microarrays promise to lead eventually to the identification of structure and function of psychophathologically relevant target genes.Keywords
This publication has 62 references indexed in Scilit:
- Cyclic AMP-dependent protein kinase in subtypes of major depression and normal volunteersInternational Journal of Neuropsychopharmacology, 1999
- Pharmacological actions of the antidepressant venlafaxine beyond aminergic receptorsInternational Journal of Neuropsychopharmacology, 1999
- The Mood‐Stabilizing Agents Lithium and Valproate RobustlIncrease the Levels of the Neuroprotective Protein bcl‐2 in the CNSJournal of Neurochemistry, 1999
- CREB AND MEMORYAnnual Review of Neuroscience, 1998
- Increased synaptic availability of norepinephrine following desipramine is not essential for increases in GR mRNAJournal of Neural Transmission, 1997
- Reduced [3H]Cyclic AMP Binding in Postmortem Brain from Subjects with Bipolar Affective DisorderJournal of Neurochemistry, 1997
- Norepinephrine-independent regulation of GRII mRNA in vivo by a tricyclic antidepressantBrain Research, 1995
- Protein kinases and phosphatases: The Yin and Yang of protein phosphorylation and signalingCell, 1995
- Differential Display of Eukaryotic Messenger RNA by Means of the Polymerase Chain ReactionScience, 1992
- Long-term antidepressant administration alters corticotropin-releasing hormone, tyrosine hydroxylase, and mineralocorticoid receptor gene expression in rat brain. Therapeutic implications.Journal of Clinical Investigation, 1991